Xilio Therapeutics, Inc.XLONASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank0
3Y CAGR-32.0%
5Y CAGR-40.5%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
-32.0%/yr
Annual compound
5Y CAGR
-40.5%/yr
Recent acceleration
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.04-60.8%
20240.11-39.1%
20230.19+31.2%
20220.14+53.1%
20210.09-84.5%
20200.60+102.9%
20190.30-